Literature DB >> 3567779

Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis.

G D Taylor, W M Wenman, D L Tyrrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3567779      PMCID： PMC1492164     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Human immune response to Giardia lamblia infection.

Authors:  G D Taylor; W M Wenman
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

2.  Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents.

Authors:  F D Gillin; L S Diamond
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

3.  Giardiasis and immunodeficiency diseases.

Authors:  A D Webster
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

4.  Chemotherapy in giardiasis: clinical responses and in vitro drug sensitivity of human isolates in axenic culture.

Authors:  P McIntyre; P F Boreham; R E Phillips; R W Shepherd
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

5.  Issues in clinical parasitology: the treatment of giardiasis.

Authors:  R A Davidson
Journal:  Am J Gastroenterol       Date:  1984-04       Impact factor: 10.864

6.  Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response.

Authors:  P D Smith; F D Gillin; W M Spira; T E Nash
Journal:  Gastroenterology       Date:  1982-10       Impact factor: 22.682

7.  IgG antibody to Giardia lamblia detected by enzyme-linked immunosorbent assay.

Authors:  P D Smith; F D Gillin; W R Brown; T E Nash
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

8.  Occurrence of specific secretory immunoglobulin A in bile after inoculation of Giardia lamblia trophozoites into rat duodenum.

Authors:  T J Loftness; S L Erlandsen; I D Wilson; E A Meyer
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682
  8 in total
  6 in total

1.  Short course combination therapy for giardiasis after nitroimidazole failure.

Authors:  Rogelio Lopez-Velez; Carolina Batlle; Carolina Jiménez; Miriam Navarro; Francesca Norman; Jose Perez-Molina
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

Review 2.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children.

Authors:  Roberto Canete; Angel A Escobedo; Maria E Gonzalez; Pedro Almirall
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

4.  Phenotypic and genotypic variation in Giardia lamblia isolates during chronic infection.

Authors:  P D Butcher; A M Cevallos; S Carnaby; E M Alstead; E T Swarbrick; M J Farthing
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 5.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

Review 6.  The biology of Giardia spp.

Authors:  R D Adam
Journal:  Microbiol Rev       Date:  1991-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.